Early response observed in pediatric patients with relapsed/refractory Burkitt lymphoma treated with chimeric antigen receptor T cells

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Burkitt Lymphoma / drug therapy
• Burkitt Lymphoma / therapy*
• Child
• Combined Modality Therapy
• Female
• Hematologic Diseases / etiology
• Humans
• Immunotherapy, Adoptive* / adverse effects
• Male
• Recurrence
• Remission Induction
• Salvage Therapy
• Treatment Outcome